M. L. Maarten L. Simoons

M. L. Maarten L. Simoons's AcademicInfluence.com Rankings

Medical

#1127

World Rank

#1435

Historical Rank

Cardiology

#71

World Rank

#72

Historical Rank

medical Degrees

Download Badge

Medical

M. L. Maarten L. Simoons's Degrees

Doctorate Medicine University of Amsterdam
PhD Cardiology Erasmus University Rotterdam

Why Is M. L. Maarten L. Simoons Influential?

(Suggest an Edit or Addition)

(See a Problem?)

M. L. Maarten L. Simoons's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. (2000) (4196)
Third universal definition of myocardial infarction. (2012) (4123)
2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. (2013) (3723)
An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. (1993) (3530)
Third universal definition of myocardial infarction (2012) (3338)
Universal definition of myocardial infarction. (2015) (2234)
Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour (1996) (1294)
Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients. GUSTO-I Investigators. (1995) (1025)
Myeloperoxidase Serum Levels Predict Risk in Patients With Acute Coronary Syndromes (2003) (974)
Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT Investigators. (2000) (970)
Third universal definition of myocardial infarction. (2012) (921)
Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. (2002) (920)
Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials (2002) (840)
A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. (1997) (832)
A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin; the Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS). (2002) (809)
A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes. (1996) (762)
Dabigatran versus warfarin in patients with mechanical heart valves. (2013) (760)
Third universal definition of myocardial infarction. (2012) (751)
Soluble CD40 ligand in acute coronary syndromes. (2003) (716)
[Guidelines on the management of stable angina pectoris: executive summary]. (2006) (705)
Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV-ACS randomised trial (2001) (682)
Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. c7E3 Fab Antiplatelet Therapy in Unstable Refractory Angina (CAPTURE) Study Investigators. (1999) (680)
The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart. (2004) (654)
THROMBOLYSIS WITH TISSUE PLASMINOGEN ACTIVATOR IN ACUTE MYOCARDIAL INFARCTION: NO ADDITIONAL BENEFIT FROM IMMEDIATE PERCUTANEOUS CORONARY ANGIOPLASTY (1988) (654)
N‐Terminal Pro‐Brain Natriuretic Peptide and Other Risk Markers for the Separate Prediction of Mortality and Subsequent Myocardial Infarction in Patients With Unstable Coronary Artery Disease: A Global Utilization of Strategies To Open occluded arteries (GUSTO)‐IV Substudy (2003) (627)
Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction. (1995) (534)
Early thrombolysis in acute myocardial infarction: limitation of infarct size and improved survival. (1986) (519)
Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion. Importance of early and complete infarct artery reperfusion. GUSTO-I Investigators. (1995) (507)
Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial. (2001) (481)
Predictive value of C-reactive protein and troponin T in patients with unstable angina: a comparative analysis. CAPTURE Investigators. Chimeric c7E3 AntiPlatelet Therapy in Unstable angina REfractory to standard treatment trial. (2000) (449)
Time from symptom onset to treatment and outcomes after thrombolytic therapy. GUSTO-1 Investigators. (1996) (438)
Management of acute coronary syndromes: acute coronary syndromes without persistent ST segment elevation; recommendations of the Task Force of the European Society of Cardiology. (2000) (418)
Third universal definition of myocardial infarction. (2012) (408)
IMPROVED SURVIVAL AFTER EARLY THROMBOLYSIS IN ACUTE MYOCARDIAL INFARCTION A Randomised Trial by the Interuniversity Cardiology Institute in The Netherlands (1985) (403)
Serum Level of the Antiinflammatory Cytokine Interleukin-10 Is an Important Prognostic Determinant in Patients With Acute Coronary Syndromes (2003) (387)
Preservation of global and regional left ventricular function after early thrombolysis in acute myocardial infarction. (1986) (363)
Perioperative cardiovascular mortality in noncardiac surgery: validation of the Lee cardiac risk index. (2005) (362)
Stroke after thrombolysis. Mortality and functional outcomes in the GUSTO-I trial. Global Use of Strategies to Open Occluded Coronary Arteries. (1995) (341)
Risk stratification for sudden cardiac death: current status and challenges for the future† (2014) (336)
Prognostic Value of Growth-Differentiation Factor-15 in Patients With Non–ST-Elevation Acute Coronary Syndrome (2007) (333)
Age, clinical presentation, and outcome of acute coronary syndromes in the Euroheart acute coronary syndrome survey. (2006) (312)
Effect of early intravenous heparin on coronary patency, infarct size, and bleeding complications after alteplase thrombolysis: results of a randomised double blind European Cooperative Study Group trial. (1992) (310)
Angiographic findings and outcome in diabetic patients treated with thrombolytic therapy for acute myocardial infarction: the GUSTO-I experience. (1996) (301)
Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction. (2002) (294)
Platelet glycoprotein IIb/IIIa receptor inhibition in non-ST-elevation acute coronary syndromes: early benefit during medical treatment only, with additional protection during percutaneous coronary intervention. (1999) (292)
Troponin and C-reactive protein have different relations to subsequent mortality and myocardial infarction after acute coronary syndrome: a GUSTO-IV substudy. (2003) (265)
Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. (2006) (264)
Randomized Trial of a GPIIb/IIIa Platelet Receptor Blocker in Refractory Unstable Angina (1994) (250)
Direct thrombin inhibitors in acute coronary syndromes: principal results of a meta-analysis based on individual patients' data (2002) (246)
Sodium-hydrogen exchange inhibition by cariporide to reduce the risk of ischemic cardiac events in patients undergoing coronary artery bypass grafting: results of the EXPEDITION study. (2008) (239)
Decline in ventricular function and clinical condition after Mustard repair for transposition of the great arteries (a prospective study of 22-29 years). (2003) (235)
Pregnancy-associated plasma protein-A levels in patients with acute coronary syndromes: comparison with markers of systemic inflammation, platelet activation, and myocardial necrosis. (2005) (233)
Effects of cardiac resynchronization therapy on overall mortality and mode of death: a meta-analysis of randomized controlled trials. (2006) (227)
Acute myocardial infarction (2003) (224)
Angiographic findings in patients with refractory unstable angina according to troponin T status. (1999) (219)
Long-term benefit of early thrombolytic therapy in patients with acute myocardial infarction: 5 year follow-up of a trial conducted by the Interuniversity Cardiology Institute of The Netherlands. (1989) (213)
Excellent survival and low incidence of arrhythmias, stroke and heart failure long-term after surgical ASD closure at young age. A prospective follow-up study of 21-33 years. (2003) (207)
Diabetes known or newly detected, but not impaired glucose regulation, has a negative influence on 1-year outcome in patients with coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart. (2006) (203)
Is transluminal coronary angioplasty mandatory after successful thrombolysis? Quantitative coronary angiographic study. (1983) (201)
Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials: a report from the Euro Heart Survey on Heart Failure. (2005) (198)
Minor Myocardial Damage and Prognosis: Are Spontaneous and Percutaneous Coronary Intervention–Related Events Different? (2002) (198)
Reperfusion injury in humans: a review of clinical trials on reperfusion injury inhibitory strategies. (2007) (191)
Long-term prognostic value of dobutamine-atropine stress echocardiography in 1737 patients with known or suspected coronary artery disease: A single-center experience. (1999) (191)
Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation The Task Force on the Management of Acute Coronary Syndromes of the European Society of Cardiology* (2002) (187)
Incidence and Predictors of Bleeding After Contemporary Thrombolytic Therapy for Myocardial Infarction (1997) (186)
Impaired microcirculation predicts poor outcome of patients with acute myocardial infarction complicated by cardiogenic shock. (2010) (176)
Outcome of patients after surgical closure of ventricular septal defect at young age: longitudinal follow-up of 22-34 years. (2004) (175)
Clinical and therapeutic profile of patients presenting with acute coronary syndromes who do not have significant coronary artery disease.The Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) Trial Investigators. (2000) (174)
Management of stable angina pectoris. Recommendations of the Task Force of the European Society of Cardiology. (1997) (172)
Prognostic value of placental growth factor in patients with acute chest pain. (2004) (167)
The Cardiology Audit and Registration Data Standards (CARDS), European data standards for clinical cardiology practice. (2005) (165)
Incidence and follow-up of Braunwald subgroups in unstable angina pectoris. (1995) (162)
Long-term outcome and quality of life in adult patients after the Fontan operation. (2004) (156)
Aortic valve and aortic arch pathology after coarctation repair (2003) (156)
The influence of peripheral arterial disease on outcomes: a pooled analysis of mortality in eight large randomized percutaneous coronary intervention trials. (2006) (155)
Clinical significance of thrombocytopenia during a non-ST-elevation acute coronary syndrome. The platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial experience. (1999) (154)
Fatty acid-binding protein and the early detection of acute myocardial infarction. (1998) (153)
Quantitative angiography of the left anterior descending coronary artery: correlations with pressure gradient and results of exercise thallium scintigraphy. (1985) (148)
Which patients benefit most from early thrombolytic therapy with intracoronary streptokinase? (1986) (147)
Abciximab in the treatment of acute myocardial infarction eligible for primary percutaneous transluminal coronary angioplasty. Results of the Glycoprotein Receptor Antagonist Patency Evaluation (GRAPE) pilot study. (1999) (147)
A dose-finding study of fondaparinux in patients with non-ST-segment elevation acute coronary syndromes: the Pentasaccharide in Unstable Angina (PENTUA) Study. (2004) (147)
Sustained Ventricular Arrhythmias Among Patients With Acute Coronary Syndromes With No ST-Segment Elevation: Incidence, Predictors, and Outcomes (2002) (144)
Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes (2002) (144)
Early detection of restenosis after successful percutaneous transluminal coronary angioplasty by exercise-redistribution thallium scintigraphy. (1985) (142)
Troponin T levels and risk of 30-day outcomes in patients with the acute coronary syndrome: prospective verification in the GUSTO-IV trial. (2003) (142)
The effect of perindopril on cardiovascular morbidity and mortality in patients with diabetes in the EUROPA study: results from the PERSUADE substudy. (2005) (137)
Patients enrolled in coronary intervention trials are not representative of patients in clinical practice: results from the Euro Heart Survey on Coronary Revascularization. (2006) (136)
Soluble CD 40 Ligand in Acute Coronary Syndromes (2003) (134)
Oral glucose tolerance test is needed for appropriate classification of glucose regulation in patients with coronary artery disease: a report from the Euro Heart Survey on Diabetes and the Heart (2006) (134)
Extended Mortality Benefit of Early Postinfarction Reperfusion (1998) (133)
Cardiac beta-myosin heavy chain defects in two families with non-compaction cardiomyopathy: linking non-compaction to hypertrophic, restrictive, and dilated cardiomyopathies. (2007) (133)
Intracranial hemorrhage in association with thrombolytic therapy: incidence and clinical predictive factors. (1992) (131)
Benefit of thrombolytic therapy is sustained throughout five years and is related to TIMI perfusion grade 3 but not grade 2 flow at discharge. The European Cooperative Study Group. (1995) (130)
Platelet glycoprotein IIb/IIIa blockade and outcome of cardiogenic shock complicating acute coronary syndromes without persistent ST-segment elevation. (2000) (130)
Impact of smoking cessation and smoking interventions in patients with coronary heart disease. (1999) (126)
Serum C-reactive protein and infarct size in myocardial infarct patients with a closed versus an open infarct-related coronary artery after thrombolytic therapy. (1993) (126)
Prior aspirin use predicts worse outcomes in patients with non-ST-elevation acute coronary syndromes. PURSUIT Investigators. Platelet IIb/IIIa in Unstable angina: Receptor Suppression Using Integrilin Therapy. (1999) (124)
Gradual Changes of ECG Waveform During and After Exercise in Normal Subjects (1975) (122)
One-Year Results From the Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries (GUSTO-I) Trial (1996) (122)
Value of admission electrocardiogram in predicting outcome of thrombolytic therapy in acute myocardial infarction. A randomized trial conducted by The Netherlands Interuniversity Cardiology Institute. (1987) (119)
Association between minor elevations of creatine kinase-MB level and mortality in patients with acute coronary syndromes without ST-segment elevation. PURSUIT Steering Committee. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy. (2000) (118)
Troponin-T and N-terminal pro-B-type natriuretic peptide predict mortality benefit from coronary revascularization in acute coronary syndromes: a GUSTO-IV substudy. (2006) (117)
Prognostic Significance of Angiogenic Growth Factor Serum Levels in Patients With Acute Coronary Syndromes (2003) (116)
Frequency, patient characteristics, and outcomes of mild-to-moderate heart failure complicating ST-segment elevation acute myocardial infarction: lessons from 4 international fibrinolytic therapy trials. (2003) (116)
Correlation between level of heparinization and patency of the infarct-related coronary artery after treatment of acute myocardial infarction with alteplase (rt-PA). (1992) (115)
Occurrence and clinical significance of pseudothrombocytopenia during abciximab therapy. (2000) (113)
Safety and prognostic value of early dobutamine-atropine stress echocardiography in patients with spontaneous chest pain and a non-diagnostic electrocardiogram. (2000) (109)
Difference in countries' use of resources and clinical outcome for patients with cardiogenic shock after myocardial infarction: results from the GUSTO trial (1997) (106)
The European trial on reduction of cardiac events with perindopril in stable coronary artery disease (EUROPA). (1998) (106)
Early percutaneous coronary intervention, platelet inhibition with eptifibatide, and clinical outcomes in patients with acute coronary syndromes. PURSUIT Investigators. (2000) (104)
Relation between infarct size and left ventricular performance assessed in patients with first acute myocardial infarction randomized to intracoronary thrombolytic therapy or to conventional treatment. (1988) (104)
Elevated placental growth factor levels are associated with adverse outcomes at four-year follow-up in patients with acute coronary syndromes. (2006) (102)
[Expert Consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease]. (2004) (100)
Anti-Platelet Factor 4/Heparin Antibodies: An Independent Predictor of 30-Day Myocardial Infarction After Acute Coronary Ischemic Syndromes (2003) (97)
Real-time transthoracic three-dimensional echocardiographic assessment of left ventricular volume and ejection fraction in congenital heart disease. (2006) (94)
Reduction of recurrent ischemia with abciximab during continuous ECG-ischemia monitoring in patients with unstable angina refractory to standard treatment (CAPTURE). (1998) (92)
Unstable angina: good long-term outcome after a complicated early course. (1998) (91)
Relative value of clinical variables, bicycle ergometry, rest radionuclide ventriculography and 24 hour ambulatory electrocardiographic monitoring at discharge to predict 1 year survival after myocardial infarction. (1986) (90)
Short- and long-term risk stratification in acute coronary syndromes: the added value of quantitative ST-segment depression and multiple biomarkers. (2006) (90)
Incidence and predictors of bleeding after contemporary thrombolytic therapy for myocardial infarction. The Global Utilization of Streptokinase and Tissue Plasminogen activator for Occluded coronary arteries (GUSTO) I Investigators. (1997) (90)
Improved reperfusion and clinical outcome with enoxaparin as an adjunct to streptokinase thrombolysis in acute myocardial infarction. The AMI-SK study. (2002) (90)
Controversies in cardiovascular medicine: Chronic stable coronary artery disease: drugs vs. revascularization. (2010) (90)
Incidence, Pathophysiology, and Treatment of Complications During Dobutamine-Atropine Stress Echocardiography (2010) (88)
Fluvastatin and bisoprolol for the reduction of perioperative cardiac mortality and morbidity in high-risk patients undergoing non-cardiac surgery: rationale and design of the DECREASE-IV study. (2004) (87)
Dose-dependent benefit of nitroglycerin on microcirculation of patients with severe heart failure (2009) (87)
Acute myocardial infarction. (2003) (86)
Reconstruction of the 12-lead electrocardiogram from reduced lead sets. (2004) (85)
Tailored Thrombolytic Therapy A Perspective (1993) (83)
Non-invasive prediction of reperfusion and coronary artery patency by continuous ST segment monitoring in the GUSTO-I trial. (1996) (82)
Disagreements between central clinical events committee and site investigator assessments of myocardial infarction endpoints in an international clinical trial: review of the PURSUIT study (2001) (82)
Selection of thrombolytic therapy for individual patients: development of a clinical model. GUSTO-I Investigators. (1997) (82)
Genetic determinants of treatment benefit of the angiotensin-converting enzyme-inhibitor perindopril in patients with stable coronary artery disease. (2010) (81)
Prediction of mortality during the first year after acute myocardial infarction from clinical variables and stress test at hospital discharge. (1985) (81)
Risk factors for in-hospital nonhemorrhagic stroke in patients with acute myocardial infarction treated with thrombolysis: results from GUSTO-I. (1998) (80)
Prognostic significance of ST segment shift early after resolution of ST elevation in patients with myocardial infarction treated with thrombolytic therapy: the GUSTO-I ST Segment Monitoring Substudy. (1998) (80)
Pre-hospital thrombolytic therapy with either alteplase or streptokinase. Practical applications, complications and long-term results in 529 patients. (1995) (80)
Long-term survival after out-of-hospital cardiac arrest: an 8-year follow-up. (1999) (80)
ST2 and mortality in non-ST-segment elevation acute coronary syndrome. (2010) (80)
Stroke in patients with acute coronary syndromes: incidence and outcomes in the platelet glycoprotein IIb/IIIa in unstable angina. Receptor suppression using integrilin therapy (PURSUIT) trial. The PURSUIT Investigators. (1999) (79)
A systematic review on pharmacogenetics in cardiovascular disease: is it ready for clinical application? (2012) (78)
Noninvasive assessment of speed and stability of infarct-related artery reperfusion: results of the GUSTO ST segment monitoring study. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. (1995) (77)
Ventricular free wall rupture: sudden, subacute, slow, sealed and stabilized varieties. (1984) (77)
Euro Heart Survey 2009 Snapshot: regional variations in presentation and management of patients with AMI in 47 countries (2013) (77)
Pre-hospital triage of patients with suspected myocardial infarction. Evaluation of previously developed algorithms and new proposals. (1995) (76)
Prognostic significance of precordial ST segment depression during inferior myocardial infarction in the thrombolytic era: results in 16,521 patients. (1996) (76)
Management of Patients With Acute Coronary Syndromes in the United States by Platelet Glycoprotein IIb/IIIa Inhibition: Insights From the Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) Trial (2000) (76)
Recurrent ischaemia during continuous multilead ST-segment monitoring identifies patients with acute coronary syndromes at high risk of adverse cardiac events; meta-analysis of three studies involving 995 patients. (2001) (75)
Cost-effectiveness of HMG coenzyme reductase inhibitors; whom to treat? (2001) (74)
Low‐dose nitroglycerin improves microcirculation in hospitalized patients with acute heart failure (2009) (73)
Estimation of the Probability of Exercise-induced Ischemia by Quantitative ECG Analysis (1977) (73)
Coronary angioplasty of the unstable angina related vessel in patients with multivessel disease. (1986) (73)
Thrombocythemia and coronary artery disease. (1991) (73)
Comparison of usefulness of computer assisted continuous 48-h 3-lead with 12-lead ECG ischaemia monitoring for detection and quantitation of ischaemia in patients with unstable angina. (1997) (73)
Impaired sublingual microvascular perfusion during surgery with cardiopulmonary bypass: a pilot study. (2008) (73)
Systematic adjudication of myocardial infarction end-points in an international clinical trial (2001) (70)
Recombinant Tissue‐Type Plasminogen Activator and Immediate Angioplasty in Acute Myocardial Infarction: One‐Year Follow‐up (1992) (70)
Indications and Outcome of Implantable Cardioverter‐Defibrillators for Primary and Secondary Prophylaxis in Patients with Noncompaction Cardiomyopathy (2011) (70)
Patients using statin treatment within 24 h after admission for ST-elevation acute coronary syndromes had lower mortality than non-users: a report from the first Euro Heart Survey on acute coronary syndromes. (2006) (69)
The Electrical T-Axis and the Spatial QRS-T Angle Are Independent Predictors of Long-Term Mortality in Patients Admitted with Acute Ischemic Chest Pain (2004) (69)
Long-term outcome after surgery for pulmonary stenosis (a longitudinal study of 22-33 years). (2006) (69)
Prehospital thrombolysis with alteplase (rt-PA) in acute myocardial infarction. (1992) (68)
Effects of early intracoronary streptokinase on infarct size estimated from cumulative enzyme release and on enzyme release rate: a randomized trial of 533 patients with acute myocardial infarction. (1986) (67)
Vectorcardiographic monitoring to assess early vessel patency after reperfusion therapy for acute myocardial infarction. (1995) (67)
Characterization of atrial septal defect assessed by real-time 3-dimensional echocardiography. (2006) (66)
Non-Q-wave versus Q-wave myocardial infarction after thrombolytic therapy: angiographic and prognostic insights from the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries-I angiographic substudy. GUSTO-I Angiographic Investigators. (1998) (66)
Cost effectiveness of perindopril in reducing cardiovascular events in patients with stable coronary artery disease using data from the EUROPA study (2006) (64)
On-line processing of orthogonal exercise electrocardiograms. (1975) (63)
Prediction of mortality following hospital discharge after thrombolysis for acute myocardial infarction: is there a need for coronary angiography? European Cooperative Study Group. (1993) (63)
Cardiovascular risk factors and clinical presentation in acute coronary syndromes (2005) (63)
The consistency of the treatment effect of an ACE-inhibitor based treatment regimen in patients with vascular disease or high risk of vascular disease: a combined analysis of individual data of ADVANCE, EUROPA, and PROGRESS trials. (2009) (62)
Exercise test, history, and serum lipid levels in patients with chest pain and normal electrocardiogram at rest: comparison to findings at coronary arteriography. (1971) (61)
Geographic variability in outcomes within an international trial of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes. Results from PURSUIT. (2000) (61)
Seven-year follow-up after dobutamine stress echocardiography: impact of gender on prognosis. (2005) (61)
Multimarker risk model containing troponin-T, interleukin 10, myeloperoxidase and placental growth factor predicts long-term cardiovascular risk after non-ST-segment elevation acute coronary syndrome (2010) (61)
Cost benefit analysis of early thrombolytic treatment with intracoronary streptokinase. Twelve month follow up report of the randomised multicentre trial conducted by the Interuniversity Cardiology Institute of The Netherlands. (1988) (60)
Retardation and arrest of progression or regression of coronary artery disease: a review. (1993) (60)
Outcomes of Patients With Acute Coronary Syndromes and Prior Coronary Artery Bypass Grafting: Results From the Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) Trial (2002) (59)
Elevated troponin T and C-reactive protein predict impaired outcome for 4 years in patients with refractory unstable angina, and troponin T predicts benefit of treatment with abciximab in combination with PTCA. (2003) (59)
Long-term effect of perindopril on coronary atherosclerosis progression (from the perindopril's prospective effect on coronary atherosclerosis by angiography and intravascular ultrasound evaluation [PERSPECTIVE] study). (2007) (58)
Confronting the issues of patient safety and investigator conflict of interest in an international clinical trial of myocardial reperfusion. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO) Steering Committee. (1992) (57)
Prediction of 30-day mortality among patients with thrombolysis-related intracranial hemorrhage. (1998) (57)
Risk of stroke associated with abciximab among patients undergoing percutaneous coronary intervention. (2001) (56)
Effect of thrombolytic treatment delay on myocardial infarct size (1992) (56)
Clinical practice guideline for cardiovascular risk management in the Netherlands. (2008) (55)
Patients with acute coronary syndromes without persistent ST elevation undergoing percutaneous coronary intervention benefit most from early intervention with protection by a glycoprotein IIb/IIIa receptor blocker. (2002) (55)
Clinical variables predicting inappropriate use of implantable cardioverter-defibrillator in patients with coronary heart disease or nonischemic dilated cardiomyopathy. (2005) (54)
The additional value of patient-reported health status in predicting 1-year mortality after invasive coronary procedures: a report from the Euro Heart Survey on Coronary Revascularisation (2006) (53)
Dynamic prognostication in non-ST-elevation acute coronary syndromes: insights from GUSTO-IIb and PURSUIT. (2004) (53)
Perspectives on large-scale cardiovascular clinical trials for the new millennium. The Virtual Coordinating Center for Global Collaborative Cardiovascular Research (VIGOUR) Group. (1997) (53)
The Cardiology Information System: the need for data standards for integration of systems for patient care, registries and guidelines for clinical practice. (2002) (52)
The effect of intracoronary thrombolysis with streptokinase on myocardial thallium distribution and left ventricular function assessed by blood-pool scintigraphy. (1982) (52)
The cardioprotective effects of the angiotensin-converting enzyme inhibitor perindopril in patients with stable coronary artery disease are not modified by mild to moderate renal insufficiency: insights from the EUROPA trial. (2007) (52)
Effect of revascularization on mortality associated with an elevated white blood cell count in acute coronary syndromes. (2003) (52)
Argatroban and Alteplase in Patients with Acute Myocardial Infarction: The ARGAMI Study (2000) (52)
Predictive value of early maximal exercise test and thallium scintigraphy after successful percutaneous transluminal coronary angioplasty. (1985) (52)
Measurement of myocardial infarct size from plasma fatty acid-binding protein or myoglobin, using individually estimated clearance rates. (1999) (51)
Quality of Hospital and Outpatient Care After Stroke or Transient Ischemic Attack: Insights From a Stroke Survey in The Netherlands (2006) (51)
Psychological and knowledge factors related to delay of help-seeking by patients with acute myocardial infarction. (1995) (50)
A comparison of methods of analysing exercise tests for diagnosis of coronary artery disease. (1989) (50)
A rapid troponin I assay is not optimal for determination of troponin status and prediction of subsequent cardiac events at suspicion of unstable coronary syndromes. (2004) (50)
Guidelines for Cardiac Management in Noncardiac Surgery Are Poorly Implemented in Clinical Practice: Results from a Peripheral Vascular Survey in The Netherlands (2007) (50)
Adverse prognosis associated with the metabolic syndrome in established coronary artery disease: data from the EUROPA trial (2007) (50)
Variation between hospitals in patient outcome after stroke is only partly explained by differences in quality of care: results from the Netherlands Stroke Survey (2008) (50)
Coronary recanalization in acute myocardial infarction: immediate results and potential risks. (1982) (49)
Optimal measurements for detection of coronary artery disease by exercise electrocardiography. (1977) (49)
ACE Inhibition and Endothelial Function: Main Findings of PERFECT, a Sub-Study of the EUROPA Trial (2007) (48)
Treatment benefit by perindopril in patients with stable coronary artery disease at different levels of risk. (2006) (48)
Prediction of mortality in hospital survivors of myocardial infarction. Comparison of predischarge exercise testing and radionuclide ventriculography at rest. (1984) (48)
A pharmacogenetic analysis of determinants of hypertension and blood pressure response to angiotensin-converting enzyme inhibitor therapy in patients with vascular disease and healthy individuals (2011) (47)
Effects of captopril in acute and chronic heart failure. Correlations with plasma levels of noradrenaline, renin, and aldosterone. (1983) (47)
Are international differences in the outcomes of acute coronary syndromes apparent or real? A multilevel analysis (2005) (47)
The incidence and clinical predictors of ACE-inhibitor induced dry cough by perindopril in 27,492 patients with vascular disease. (2014) (47)
Heart rate variability index in congestive heart failure: relation to clinical variables and prognosis. (1998) (47)
Comparison of Candesartan versus Metoprolol for treatment of systemic hypertension after repaired aortic coarctation. (2010) (46)
Changes in Clinical Profile, Treatment, and Mortality in Patients Hospitalised for Acute Myocardial Infarction between 1985 and 2008 (2011) (46)
Prognostic stratification using dobutamine stress 99mTc-tetrofosmin myocardial perfusion SPECT in elderly patients unable to perform exercise testing. (2005) (45)
Assessment of coronary angiograms prior to and after treatment with abciximab, and the outcome of angioplasty in refractory unstable angina patients. Angiographic results from the CAPTURE trial. (1999) (45)
Toward the optimal lead system and optimal criteria for exercise electrocardiography. (1981) (45)
Extended mortality benefit of early postinfarction reperfusion. GUSTO-I Angiographic Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries Trial. (1998) (44)
Increased serum levels of fibrinogen degradation products due to treatment with recombinant tissue-type plasminogen activator for acute myocardial infarction are related to bleeding complications, but not to coronary patency (1989) (44)
Low prevalence of cardiac abnormalities in an HIV-seropositive population on antiretroviral combination therapy. (2001) (44)
Conventional Hemodynamic Resuscitation May Fail to Optimize Tissue Perfusion: An Observational Study on the Effects of Dobutamine, Enoximone, and Norepinephrine in Patients with Acute Myocardial Infarction Complicated by Cardiogenic Shock (2014) (44)
Feasibility and accuracy of real-time 3-dimensional echocardiographic assessment of ventricular septal defects. (2006) (44)
The Effects of Intra-Aortic Balloon Pump Support on Macrocirculation and Tissue Microcirculation in Patients with Cardiogenic Shock (2009) (43)
A simplified continuity equation approach to the quantification of stenotic bicuspid aortic valves using velocity-encoded cardiovascular magnetic resonance. (2007) (43)
Prehospital versus hospital fibrinolytic therapy using automated versus cardiologist electrocardiographic diagnosis of myocardial infarction: abortion of myocardial infarction and unjustified fibrinolytic therapy. (2004) (43)
Enzyme tests in the evaluation of thrombolysis in acute myocardial infarction. (1988) (43)
[Guideline 'Cardiovascular Risk Management']. (2007) (43)
Usefulness of biomarkers for predicting long-term mortality in patients with diabetes mellitus and non-ST-elevation acute coronary syndromes (a GUSTO IV substudy). (2006) (43)
Mortality, reinfarction, left ventricular ejection fraction and costs following reperfusion therapies for acute myocardial infarction. (1996) (42)
Clinical synergy of perindopril and calcium-channel blocker in the prevention of cardiac events and mortality in patients with coronary artery disease. Post hoc analysis of the EUROPA study. (2010) (42)
Usefulness of intra-aortic balloon pump counterpulsation in patients with cardiogenic shock from acute myocardial infarction. (2009) (42)
Rapid and accurate measurement of LV mass by biplane real-time 3D echocardiography in patients with concentric LV hypertrophy: comparison to CMR. (2007) (41)
Reasons for the lack of benefit of immediate angioplasty during recombinant tissue plasminogen activator therapy for acute myocardial infarction: a regional wall motion analysis. European Cooperative Study Group. (1991) (41)
Neurosurgical evacuation of intracranial hemorrhage after thrombolytic therapy for acute myocardial infarction: experience from the GUSTO-I trial. Global Utilization of Streptokinase and tissue-plasminogen activator (tPA) for Occluded Coronary Arteries. (1999) (41)
Differential effects of tissue plasminogen activator and streptokinase on infarct size and on rate of enzyme release: influence of early infarct related artery patency. The GUSTO Enzyme Substudy. (1996) (41)
Atrial fibrillation and mortality among patients with acute coronary syndromes without ST-segment elevation: results from the PURSUIT trial. (2001) (40)
Clinical and Therapeutic Profile of Patients Presenting With Acute Coronary Syndromes Who Do Not Have Significant Coronary Artery Disease (2000) (40)
Attenuation of Rebound Ischemia After Discontinuation of Heparin Therapy by Glycoprotein IIb/IIIa Inhibition With Eptifibatide in Patients With Acute Coronary Syndromes: Observations From the Platelet IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) Trial (2001) (40)
REDUCED FREQUENCY OF VENTRICULAR FIBRILLATION AFTER EARLY THROMBOLYSIS IN MYOCARDIAL INFARCTION (1986) (40)
Noninvasive assessment of reperfusion and reocclusion after thrombolysis in acute myocardial infarction. (1993) (40)
Long-term prognostic value of dobutamine stress echocardiography compared with myocardial perfusion scanning in patients unable to perform exercise tests (2004) (40)
Implementation of a pre-hospital decision rule in general practice. Triage of patients with suspected myocardial infarction. (1996) (39)
The Prevalence of Early Repolarization in Patients with Noncompaction Cardiomyopathy Presenting with Malignant Ventricular Arrhythmias (2012) (39)
Cost effectiveness of eptifibatide in acute coronary syndromes; an economic analysis of Western European patients enrolled in the PURSUIT trial. The Platelet IIa/IIb in unstable Angina: Receptor Suppression Using Integrilin Therapy. (2002) (38)
Mechanical circulatory support devices improve tissue perfusion in patients with end-stage heart failure or cardiogenic shock. (2009) (38)
Quantitation of exercise electrocardiography. (1981) (38)
Patient and doctor delay in acute myocardial infarction: a study in Rotterdam, The Netherlands. (1995) (38)
Selection of reperfusion therapy for individual patients with evolving myocardial infarction. (1997) (38)
Safety and efficacy of abciximab combined with dalteparin in treatment of acute coronary syndromes. (2002) (37)
Combined Therapy With Streptokinase and Integrilin (1998) (37)
Early detection of left ventricular dysfunction by Doppler tissue imaging and N-terminal pro-B-type natriuretic peptide in patients with symptomatic severe aortic stenosis. (2008) (37)
Bleeding events with abciximab in acute coronary syndromes without early revascularization: An analysis of GUSTO IV-ACS. (2004) (37)
Estimated gain in life expectancy. A simple tool to select optimal reperfusion treatment in individual patients with evolving myocardial infarction. (1996) (36)
Therapeutic value of eptifibatide at community hospitals transferring patients to tertiary referral centers early after admission for acute coronary syndromes. PURSUIT Investigators. (2001) (36)
Consequences of a selective approach toward pulmonary valve replacement in adult patients with tetralogy of Fallot and pulmonary regurgitation. (2008) (36)
Acute coronary syndromes complicated by symptomatic and asymptomatic heart failure: does current treatment comply with guidelines? (2003) (36)
[Guidelines on the management of stable angina pectoris; the experts of the European Society of Cardiology on the management of stable angina pectoris]. (2006) (35)
Myocardial revascularization--bypass surgery or angioplasty? (1996) (35)
Surgical validation of real-time transthoracic 3D echocardiographic assessment of atrioventricular septal defects. (2006) (35)
Rationale and clinical evidence for the use of GP IIb/IIIa inhibitors in acute coronary syndromes. (1998) (35)
Coronary artery disease after heart transplantation: timing of coronary arteriography. (1993) (34)
Anticoagulant properties, clinical efficacy and safety of efegatran, a direct thrombin inhibitor, in patients with unstable angina. (1999) (34)
Safety and efficacy of eptifibatide vs placebo in patients receiving thrombolytic therapy with streptokinase for acute myocardial infarction; a phase II dose escalation, randomized, double-blind study. (2000) (34)
Quantitative Analysis of Exercise Electrocardiograms and Left Ventricular Angiocardiograms in Patients with Abnormal QRS Complexes at Rest (1977) (33)
Long-term prediction of mortality in elderly persons by dobutamine stress echocardiography. (2005) (33)
Long-term survival after successful out-of-hospital resuscitation. (1994) (33)
Long term improvement in global left ventricular function after early thrombolytic treatment in acute myocardial infarction. Report of a randomised multicentre trial of intracoronary streptokinase in acute myocardial infarction. (1986) (32)
Elevated creatine kinase-MB with normal creatine kinase predicts worse outcomes in patients with acute coronary syndromes: results from 4 large clinical trials. (2006) (32)
Angiotensin-converting enzyme inhibition by perindopril in the treatment of cardiovascular disease (2009) (32)
Assessment of coronary reperfusion in patients with myocardial infarction using fatty acid binding protein concentrations in plasma (2001) (32)
Prognostic significance of left anterior hemiblock in patients with suspected coronary artery disease. (2005) (32)
Early angioplasty in acute coronary syndromes without persistent ST-segment elevation improves outcome but increases the need for six-month repeat revascularization: an analysis of the PURSUIT Trial. Platelet glycoprotein IIB/IIIA in Unstable angina: Receptor Suppression Using Integrilin Therapy. (2002) (32)
Value of troponins in predicting therapeutic efficacy of abciximab in patients with unstable angina (1998) (31)
Real-time transthoracic three-dimensional echocardiography provides additional information of left-sided AV valve morphology after AVSD repair. (2006) (31)
Abnormal aortic elastic properties in adults with congenital valvular aortic stenosis. (2008) (31)
Development and validation of a cardiovascular risk assessment model in patients with established coronary artery disease. (2013) (31)
Costs and effects of c7E3 in high risk PTCA patients. An indirect analysis for The Netherlands. (1995) (31)
The benefit of abciximab in percutaneous coronary revascularization is not device-specific. (2000) (30)
Effects of stroke on medical resource use and costs in acute myocardial infarction. GUSTO I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries Study. (1999) (30)
[Guidelines on the management of stable angina pectoris. Executive summary]. (2006) (30)
Sustained benefit 20 years after reperfusion therapy in acute myocardial infarction. (2006) (30)
Comparison of peak serum C-reactive protein and hydroxybutyrate dehydrogenase levels in patients with acute myocardial infarction treated with alteplase and streptokinase. (1997) (30)
Expert Consensus Document. Third Universal Definition of Myocardial Infarction (2013) (30)
Secondary Prevention of Coronary Disease with ACE Inhibition-does Blood Pressure Reduction with Perindopril Explain the Benefits in EUROPA? (2009) (30)
Expert Consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease (2004) (30)
Clinical course after attempted thrombolysis in myocardial infarction. Results of pilot studies and preliminary data from a randomized trial. (1982) (28)
Dynamic 3D echocardiography in virtual reality (2005) (28)
Prognostic value of dobutamine stress echocardiography in patients with previous coronary revascularisation (2004) (28)
Efficacy of perindopril in reducing risk of cardiac events in patients with revascularized coronary artery disease. (2007) (28)
Indirect enzyme-linked immunosorbent assay for immunoglobulin G and four immunoassays for immunoglobulin M to Toxoplasma gondii in a series of heart transplant recipients (1989) (28)
Bleeding complications of intracoronary fibrinolytic therapy in acute myocardial infarction. Assessment of risk in a randomised trial. (1985) (27)
Improved reperfusion and clinical outcome with enoxaparin as an adjunct to streptokinase thrombolysis in acute myocardial infarction: the AMI-SK study☆ (2003) (27)
Pulsed-wave transmitral Doppler do not diagnose moderate acute rejection after heart transplantation. (1993) (27)
Platelet glycoprotein IIB/IIIA receptor antagonists. An asset for treatment of unstable coronary syndromes and coronary intervention. (1998) (27)
gINTELLIGENCE EXPERT C ONSENSUS DOCUMENT Third Universal Definition of Myocardial Infarction (2012) (27)
Frequency of asymptomatic disease among family members with noncompaction cardiomyopathy. (2012) (27)
Clinical and prognostic implications of circulating pentraxin 3 levels in non ST-elevation acute coronary syndrome. (2013) (27)
Long term benefit of early thrombolytic therapy in patients with acute myocardial infarction (1989) (27)
Intra-operative assessment of human pulmonary alveoli in vivo using Sidestream Dark Field imaging: a feasibility study. (2009) (27)
The Rationale and Design of the Perindopril Genetic Association Study (PERGENE): A Pharmacogenetic Analysis of Angiotensin-Converting Enzyme Inhibitor Therapy in Patients with Stable Coronary Artery Disease (2009) (26)
Sustained Benefit 20 Years After Reperfusion Therapy in Acute Myocardial Infarction (2005) (26)
Risk factors for intracranial hemorrhage and nonhemorrhagic stroke after fibrinolytic therapy (from the GUSTO-i trial). (2004) (26)
'Expected infarct size without thrombolysis', a concept that predicts immediate and long-term benefit from thrombolysis for evolving myocardial infarction. (1997) (25)
Limitations of a QRS scoring system to assess left ventricular function and prognosis at hospital discharge after myocardial infarction. (1985) (25)
The need for resources for clinical research: the European Society of Cardiology calls for European, international collaboration (2002) (25)
Prehospital thrombolysis with reteplase: the Nijmegen/Rotterdam study. (2003) (24)
ACE inhibition with perindopril and biomarkers of atherosclerosis and thrombosis: results from the PERTINENT study. (2009) (24)
Prognostic significance of QRS duration in patients with suspected coronary artery disease referred for noninvasive evaluation of myocardial ischemia. (2009) (24)
Creatine kinase-MB elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromes. (2004) (24)
Continuous ST-segment monitoring associated with infarct size and left ventricular function in the GUSTO-I trial. (1999) (24)
Impact of an alerting clinical decision support system for glucose control on protocol compliance and glycemic control in the intensive cardiac care unit. (2011) (24)
Management of cardiogenic shock: focus on tissue perfusion. (2009) (24)
Changes in left ventricular function and wall thickness in heart transplant recipients and their relation to acute rejection: an assessment by digitised M mode echocardiography (1992) (24)
Prognosis of patients with different peak serum creatine kinase levels after first myocardial infarction. (1985) (24)
The Cardiac Infarction Injury Score as a predictor for long-term mortality in survivors of a myocardial infarction. (1998) (23)
The Treatment Effect of an ACE-Inhibitor Based Regimen with Perindopril in Relation to Beta-Blocker use in 29,463 Patients with Vascular Disease: a Combined Analysis of Individual Data of ADVANCE, EUROPA and PROGRESS Trials (2017) (23)
Prospective study of early discharge after acute myocardial infarction (SHORT) (2000) (23)
Effects of platelet glycoprotein IIb/IIIa receptor blockers in non-ST segment elevation acute coronary syndromes: benefit and harm in different age subgroups (2006) (23)
Cigarette smoking status and outcome among patients with acute coronary syndromes without persistent ST-segment elevation: effect of inhibition of platelet glycoprotein IIb/IIIa with eptifibatide. The PURSUIT trial investigators. (2000) (23)
The in vitro effect of the new antithrombotic drug candidate ALX-0081 on blood samples of patients undergoing percutaneous coronary intervention (2011) (23)
[Guidelines and costs]. (1998) (22)
Activation of the inflammation, coagulation, and fibrinolysis systems, without influence of abciximab infusion in patients with non-ST-elevation acute coronary syndromes treated with dalteparin: a GUSTO IV substudy. (2004) (22)
Costs and effects in therapy for acute coronary syndromes: the case of abciximab in high-risk patients undergoing percutaneous transluminal coronary angioplasty in the EPIC study. Evaluation of 7E3 for the Prevention of Ischemic Complications. (1998) (22)
Myocardial infarction: ACE inhibitors for all? for ever? (1994) (22)
Prognostic implications of a normal stress technetium-99m-tetrofosmin myocardial perfusion study in patients with a healed myocardial infarct and/or previous coronary revascularization. (2006) (22)
Long-term prognostic value of serial troponin T bedside tests in patients with acute coronary syndromes. (2000) (21)
Reliable Assessment of Sedation Level in Routine Clinical Practice by Adding an Instruction to the Ramsay Scale (2009) (21)
Ineligibility for predischarge exercise testing after myocardial infarction in the elderly: implications for prognosis. (1984) (21)
Pacemaker stress echocardiography predicts cardiac events in patients with permanent pacemaker. (2005) (21)
Sequential OKT3 and cyclosporine after heart transplantation : a randomized study with single and cyclic OKT3 (1991) (21)
The challenge of acute coronary syndromes (1999) (21)
Retreatment with alteplase for early signs of reocclusion after thrombolysis. The European Cooperative Study Group. (1993) (21)
High-Frequency Biomarker Measurements of Troponin, NT-proBNP, and C-Reactive Protein for Prediction of New Coronary Events After Acute Coronary Syndrome. (2019) (21)
Rapid enzyme release from acutely infarcted myocardium after early thrombolytic therapy: washout or reperfusion damage? (1988) (21)
Cardiovascular Diseases in Europe Euro Heart Survey and National Registries of Cardiovascular Diseases and Patient Management (2006) (20)
Practical guidelines for treatment with beta-blockers and nitrates in patients with acute myocardial infarction. (1983) (20)
Outcomes of patients with acute coronary syndromes and prior percutaneous coronary intervention: a pooled analysis of three randomized clinical trials. (2005) (20)
Perindopril and β-blocker for the prevention of cardiac events and mortality in stable coronary artery disease patients: A EUropean trial on Reduction Of cardiac events with Perindopril in stable coronary Artery disease (EUROPA) subanalysis. (2015) (20)
Value of predischarge data for the prediction of exercise capacity after cardiac rehabilitation in patients with recent myocardial infarction. (1987) (20)
Predictors of left ventricular function after acute myocardial infarction: effects of time to treatment, patency, and body mass index: the GUSTO-I angiographic experience. (2001) (20)
Effects of perindopril on long-term clinical outcome of patients with coronary artery disease and preserved left ventricular function. (2007) (20)
Ridogrel as an adjunct to thrombolysis in acute myocardial infarction. (1995) (19)
Rationale and clinical evidence for the use of GP IIb/IIIa inhibitors in acute coronary syndromes. (1998) (19)
Prediction of 1-year outcome after complicated and uncomplicated myocardial infarction: Bayesian analysis of predischarge exercise test results in 300 patients. (1987) (19)
Safety and preliminary efficacy of one month glycoprotein IIb/IIIa inhibition with lefradafiban in patients with acute coronary syndromes without ST-elevation; a phase II study. (2000) (19)
Circadian variation of heart rate but not of blood pressure after heart transplantation. (1987) (19)
Changes in the electrocardiographic response to exercise in healthy women. (1990) (19)
Intracoronary thrombolysis in patients with acute myocardial infarction: the Netherlands Randomized Trial and current status. (1987) (19)
Creatine kinase-MB elevation after coronary artery bypass grafting surgery in patients with non-ST-segment elevation acute coronary syndromes predict worse outcomes: results from four large clinical trials. (2007) (19)
Cohort profile of BIOMArCS: the BIOMarker study to identify the Acute risk of a Coronary Syndrome—a prospective multicentre biomarker study conducted in the Netherlands (2016) (18)
Variation in the use of coronary angiography in patients with unstable angina is related to differences in patient population and availability of angiography facilities, without affecting prognosis. (1996) (18)
Combining baseline clinical descriptors and real-time response to therapy: the incremental prognostic value of continuous ST-segment monitoring in acute myocardial infarction. (2004) (18)
Prediction of 30-Day Mortality in Older Patients with a First Acute Myocardial Infarction (2009) (18)
Glycoprotein IIb/IIIa receptor blockers in acute coronary syndromes (2001) (18)
Tissue plasminogen activator in refractory unstable angina. A randomized double-blind placebo-controlled trial in patients with refractory unstable angina and subsequent angioplasty. (1991) (17)
Insight into ACE inhibition in the prevention of cardiac events in stable coronary artery disease: the EUROPA trial (2007) (17)
Predischarge stress test after myocardial infarction in the old age: results and prognostic value. (1984) (16)
Thrombolysis-induced coronary reperfusion causes acute and massive interstitial release of cardiac muscle cell proteins. (1997) (16)
Sustained benefit at 10-14 years follow-up after thrombolytic therapy in myocardial infarction. (1999) (16)
Enhanced sensitivity of dobutamine stress echocardiography by observing wall motion abnormalities during the recovery phase after acute beta-blocker administration. (2006) (16)
Prior aspirin use predicts worse outcomes in patients with non–ST-elevation acute coronary syndromes11This study was sponsored by COR Therapeutics Inc., South San Francisco, California; and Schering-Plough Research Institute, Kenilworth, New Jersey. (1999) (16)
Identifying genetic risk variants for coronary heart disease in familial hypercholesterolemia: an extreme genetics approach (2014) (16)
Predictors of stroke within 30 days in patients with non-ST-segment elevation acute coronary syndromes. (2006) (16)
Thrombolytic therapy in acute myocardial infarction. (1989) (16)
Prognosis of patients undergoing cardiac surgery and treated with intra-aortic balloon pump counterpulsation prior to surgery: a long-term follow-up study. (2009) (16)
Evaluating the benefits of glycoprotein IIb/IIIa inhibitors in heart failure at baseline in acute coronary syndromes. (2004) (16)
Haemodynamic effects of alinidine, a specific sinus node inhibition, in patients with unstable angina or myocardial infarction. (1984) (16)
Sex-related aspects on abnormal glucose regulation in patients with coronary artery disease. (2007) (16)
Risk-Benefit Of Thrombol Ysis (1995) (16)
EUROPA substudies, confirmation of pathophysiological concepts. European trial on reduction of cardiac events with perindopril in stable coronary artery disease. (1998) (15)
Surgical versus non-surgical management of patients soon after acute myocardial infarction. (1985) (15)
Improving adherence to guidelines for acute stroke management. (2009) (15)
Tailored therapy of ACE inhibitors in stable coronary artery disease: pharmacogenetic profiling of treatment benefit. (2010) (15)
Alinidine, a new agent which lowers heart rate in patients with angina pectoris. (1982) (15)
Value of immediate coronary angioplasty following intracoronary thrombolysis in acute myocardial infarction. (1987) (15)
Simultaneous comparison of 3 derived 12-lead electrocardiograms with standard electrocardiogram at rest and during percutaneous coronary occlusion. (2008) (15)
Long-term prognostic value of dobutamine stress echocardiography compared with myocardial perfusion scanning in patients unable to perform exercise tests. (2004) (15)
Well shaped ST segment and risk of cardiovascular mortality. (1992) (15)
Treatment and prevention of coronary heart disease by lowering serum cholesterol levels; from the pioneer work of C.D. de Langen to the third "Dutch Consensus on Cholesterol". (1999) (15)
QRS changes in coronary artery disease. (1979) (14)
Antibodies to Platelet Factor 4/Heparin are Associated with Elevated Endothelial Cell Activation Markers in Patients with Acute Coronary Ischemic Syndromes (2004) (14)
Recurrent ischemia during continuous 12-lead ECG-ischemia monitoring in patients with acute coronary syndromes treated with eptifibatide: relation with death and myocardial infarction. PURSUIT ECG-Ischemia Monitoring Substudy Investigators. Platelet glycoprotein IIb/IIIa in Unstable angina: Receptor (2000) (14)
Antibodies to chlamydial lipopolysaccharides in unstable angina pectoris. (2001) (13)
Diagnostic merits of exercise testing in females. (1989) (13)
DOUBLE FAILURE OF INFLUENZA VACCINATION IN A HEART TRANSPLANT PATIENT (1987) (13)
Letter to the Editor. Effect of thrombolytic treatment delay on myocardial infarct size (1992) (13)
5-Hydroxytryptamine-induced contractions of the human isolated saphenous vein: involvement of 5-HT2 and 5-HT1D-like receptors, and a comparison with grafted veins (2004) (13)
One-year results from the Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries (GUSTO-I) trial. GUSTO-I Investigators. (1996) (13)
Cardio-vascular disease in Europe: challenges for the medical profession. Opening address of the 2002 Congress European Society of Cardiology. (2003) (13)
On-Line Analysis of Exercise Electrocardiograms (1975) (13)
Trends in clinical trials of non-ST-segment elevation acute coronary syndromes over 15 years. (2013) (12)
Cytoimmunological monitoring of heart transplant recipients (1990) (12)
Exercise Electrocardiography and Exercise Testing (2010) (12)
Risk stratification of patients with classic angina pectoris and no history of coronary artery disease by dobutamine stress echocardiography. (2005) (12)
Individualized Angiotensin‐Converting Enzyme (ACE)‐Inhibitor Therapy in Stable Coronary Artery Disease Based on Clinical and Pharmacogenetic Determinants: The PERindopril GENEtic (PERGENE) Risk Model (2016) (12)
Reperfusion in acute myocardial infarction (2005) (12)
Platelet GP IIb/IIIa receptor blockers for failed thrombolysis in acute myocardial infarction, alone or as adjunct to other rescue therapies; single centre retrospective analysis of 548 consecutive patients with acute myocardial infarction. (2002) (12)
High fat intake in hyperlipidaemic patients is related to male gender, smoking, alcohol intake and obesity. (2001) (12)
Thrombolytic therapy for evolving myocardial infarction needs an approach that integrates benefit and risk. (1995) (12)
Encouraging survival rates in patients with acute myocardial infarction treated with an intra-aortic balloon pump (2011) (11)
Comparison of all-cause mortality in women with known or suspected coronary artery disease referred for dobutamine stress echocardiography with normal versus abnormal test results. (2005) (11)
Optimal use of coronary care units: a review. (1995) (11)
EUROPA substudies, confirmation of pathophysiological concepts (1998) (11)
Heart rate levels and ventricular ectopic activity during cardiac rehabilitation. (1980) (11)
Simultaneous comparison of three derived 12-lead ECGs with standard ECG at rest and during percutaneous coronary occlusion. (2004) (11)
Reperfusion in acute myocardial infarction. International Society and Federation of Cardiology and World Health Organization Task Force on Myocardial Reperfusion. (1994) (11)
Scientific integrity: what a journal can and cannot do. (2020) (11)
Congenital aortic stenosis in adults: rate of progression and predictors of clinical outcome. (2007) (11)
The effect of ITF-1697 on reperfusion in patients undergoing primary angioplasty. Safety and efficacy of a novel tetrapeptide, ITF-1697. (2004) (11)
Time-dependent diagnostic performance of a rapid troponin T version 2 bedside test in patients with acute coronary syndromes. (2000) (10)
The Medical Profession, Industry, and Continuing Medical Education: Finding the Balance That's Right for Patients. (2019) (10)
Hemoptysis after flushing Swan-Ganz catheters in the wedge position. (1981) (10)
Passive immunization against cytomegalovirus in allograft recipients. The Rotterdam heart transplant program experience (1993) (10)
Strategies for pre-hospital thrombolysis: an overview. (1991) (10)
Pharmacogenetics of ACE inhibition in stable coronary artery disease: steps towards tailored drug therapy (2008) (10)
Global utilization of streptokinase and tPA for occluded arteries (GUSTO) ECG-monitoring substudy. Study design and technical considerations. (1993) (10)
Third universal definition of myocardial (2012) (10)
The need for resources for clinical research: proceedings of a policy conference held at the European Heart House, 27-28 June 2002: executive summary. (2003) (10)
Feelings of being disabled as a risk factor for mortality up to 8 years after acute myocardial infarction. (2005) (10)
Incremental prognostic value of dobutamine–atropine stress 99mTc-tetrofosmin myocardial perfusion imaging for predicting outcome in diabetic patients with limited exercise capacity (2005) (10)
Incidence and prognostic implications of repetitive ventricular complexes during pre-discharge bicycle ergometry after myocardial infarction. (1987) (10)
Myocardial salvage by intracoronary thrombolysis in acute infarcts, documentation by thallium scintigraphy (1982) (10)
Effect of beta-blockers on the relation between QT-interval and heart rate in exercise ECG. (1987) (10)
Antithrombotic outcome trials in acute coronary syndromes: seeking the optimal balance between safety and efficacy. (2013) (10)
Cytoimmunological monitoring to detect rejection after heart transplantation. (1989) (10)
Randomized trial of deferred angioplasty after thrombolysis for acute myocardial infarction (1992) (10)
Impact of diabetes mellitus on prediction of clinical outcome after coronary revascularization by 18F-FDG SPECT in patients with ischemic left ventricular dysfunction. (2006) (9)
Immediate angioplasty: a conservative view from Europe. (1995) (9)
Angiotensin-converting enzyme inhibition with perindopril in patients with prior myocardial infarction and/or revascularization: a subgroup analysis of the EUROPA trial. (2009) (9)
Assessment of derived 12-lead electrocardiograms using general and patient-specific reconstruction strategies at rest and during transient myocardial ischemia. (2004) (9)
ST-Vector Orientation and Location of Myocardial Perfusion Defects during Exercise (1978) (9)
Effect of adopting a new histological grading system of acute rejection after heart transplantation (1997) (9)
Meeting report ESC forum on drug eluting stents, European Heart House, Nice, 27-28 September 2007. (2009) (9)
Characteristics, Treatment and Outcome of Patients with Non-ST-Elevation Acute Coronary Syndromes and Multivessel Coronary Artery Disease: Observations from PURSUIT (Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrelin Therapy) (2002) (9)
Contribution of nursing to risk factor management as perceived by patients with established coronary heart disease. (2002) (8)
Prediction of absolute risk reduction of cardiovascular events with perindopril for individual patients with stable coronary artery disease - results from EUROPA. (2015) (8)
Risk-benefit of thrombolysis. (1995) (8)
[Therapy and prevention of coronary heart diseases through lowering of the serum cholesterol levels; third consensus 'Cholesterol'. Consensus Working Group, CBO]. (1998) (8)
Erratum to "Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation" (Eur Heart J (2002) 23, 1809-1840) (2003) (8)
Antiplatelet therapy in therapy-resistant unstable angina. A pilot study with REO PRO (c7E3). (1995) (8)
[Long-term survival following successful resuscitation outside the hospital]. (1991) (8)
Prognostic stratification of patients with right bundle branch block using dobutamine stress echocardiography. (2004) (8)
Estimated gain in life expectancy (1996) (8)
The role of insulin therapy and glucose normalisation in patients with acute coronary syndrome (2011) (8)
Thrombolysis with rt-PA in acute myocardial infarction: no additional benefit of immediate PTCA (1988) (8)
Immediate PTCA after successful thrombolysis with intracoronary streptokinase, three years follow-up. A matched pair analysis of the effect of PTCA in the randomized multicentre trial of intracoronary streptokinase, conducted by the Interuniversity Cardiology Institute of The Netherlands. (1988) (8)
Prognostic significance of nonfatal myocardial reinfarction in survivors of a first infarction. (2001) (8)
Role of echocardiography in acute coronary syndromes. (2004) (8)
Echocardiography in the Coronary Care Unit (1984) (7)
Effects of nifedipine on left ventricular performance in unstable angina pectoris during a follow-up of 48 hours. (1986) (7)
Thrombolytic therapy for acute coronary obstruction: status in 1986. (1986) (7)
A pharmacokinetic study of anti-cytomegalovirus hyperimmunoglobulins in cytomegalovirus seronegative cardiac transplant recipients. (1987) (7)
Reduction in the need for unplanned stenting with the use of platelet glycoprotein IIb/IIIa blockade in percutaneous coronary intervention. (1998) (7)
Long-Term Results After the Glycoprotein IIb/IIIa Inhibitor Abciximab in Unstable Angina (2003) (7)
Process of care partly explains the variation in mortality between hospitals after peripheral vascular surgery. (2010) (7)
Coronary artery disease: prevention of progression and prevention of events. (1995) (6)
Myocardial technetium-99m-tetrofosmin single-photon emission computed tomography compared with 18F-fluorodeoxyglucose imaging to assess myocardial viability. (2005) (6)
Genetic influences of angiotensin-converting enzyme inhibitor response: an opportunity for personalizing therapy? (2012) (6)
Improvement of myocardial perfusion after thrombolysis assessed by thallium-201 exercise scintigraphy. Report of the Working Group on Thrombolytic Therapy in Acute Myocardial Infarction of the Netherlands Interuniversity Institute of Cardiology. (1988) (6)
First results of abciximab (ReoPro) in the treatment of acute myocardial infarction and primary PTCA: the GRAPE pilot study (1997) (6)
Obesity, cardiology, and beyond. (2008) (6)
Treatment of stable angina pectoris with verapamil hydrochloride: a double blind cross-over study. (1980) (6)
Clinical value of exercise testing in elderly patients. (1984) (6)
Evaluation of a clinical decision support system for glucose control: impact of protocol modifications on compliance and achievement of glycemic targets. (2010) (6)
Model studies on activation of the heart. (1978) (6)
The prophylactic use of Orthoclone OKT3 in kidney and heart transplantation. (1988) (5)
A Review of the Long Term Effects of Thrombolytic Agents (2000) (5)
[Cholesterol-lowering therapy; a recommendation from the Health Council]. (2000) (5)
No relationship between left ventricular radial wall motion and longitudinal velocity and the extent and severity of noncompaction cardiomyopathy (2012) (5)
755-5 Risk Factors for Stroke Following Thrombolytic Therapy: Case-Control Study from the GUSTO Trial (1995) (5)
Three life years gained after reperfusion therapy in acute myocardial infarction: 25−30 years after a randomized controlled trial (2012) (5)
Does eptifibatide confer a greater benefit to patients with unstable angina than with non-ST segment elevation myocardial infarction? Insights from the PURSUIT Trial. (2002) (5)
Transient exacerbation of ST-segment elevation upon reperfusion in acute myocardial infarction. (1993) (5)
Too early for cardiac transplantation--the right decision? (1992) (5)
Risk Factors for In-hospital Nonhemorrhagic Stroke in Patients With Acute Myocardial Infarction Treated With Thrombolysis: Results from GUSTO-I : Results From Gusto-I (1998) (5)
Intravenous rt-PA for acute myocardial infarction: which patients benefit most? (1988) (5)
Intensive LDL lowering therapy for prevention of recurrent cardiovascular events: a word of caution. (2016) (5)
Computer-generated discharge letters in the coronary care unit. (1985) (5)
New directions in anticoagulant and antiplatelet treatment. (1995) (5)
Pharmacodynamics and safety of lefradafiban, an oral platelet glycoprotein IIb/IIIa receptor antagonist, in patients with stable coronary artery disease undergoing elective angioplasty (2001) (5)
HMG-coenzym a reductase inhibitors: drugselection by means of the soja method (1999) (5)
Benefits and risks of thrombolysis for acute myocardial infarction (1990) (5)
Which Factors Are Associated with the Application of Reperfusion Therapy in ST-Elevation Acute Coronary Syndromes? (2006) (5)
Polyclonal versus monoclonal rejection prophylaxis after heart transplantation: a randomised study. (1992) (5)
Thrombolytic therapy for acute coronary thrombosis. (1987) (5)
Complementarity of stenting and abciximab for percutaneous coronary intervention (1998) (5)
The Paceport catheter: a new pacemaker system introduced through a Swan-Ganz catheter. (1988) (4)
Prognostic importance of new small Q waves following non-ST-elevation acute coronary syndromes. (2003) (4)
Does red blood cell transfusion result in a variate microvascular response in sepsis? (2007) (4)
Dronedarone in patients with atrial fibrillation (2010) (4)
The ESC Publications Ethics Committee: Report from the first 5 years’ experience of the European Society of Cardiology (ESC) journals family ethics committee (2018) (4)
Hemodynamic effects of sulmazol (ARL-115 BS), a new vasodilator and positive inotropic agent, in patients with cardiogenic shock. (1983) (4)
The effects of drugs on the exercise electrocardiogram. (1981) (4)
European cardiology 2000-2002. (2001) (4)
[Twelve year triage and thrombolysis treatment prior to hospitalization for myocardial infarction patients in the Rotterdam area of the Netherlands: outstanding short-term and long-term results]. (2001) (4)
Reperfusion Therapy for Acute Myocardial Infarction (2012) (4)
Characterization of myocardial infarction as an end point in two large trials of acute coronary syndromes. (2005) (4)
Influence of nifedipine on left ventricular perfusion and function in patients with unstable angina: Evaluation with radionuclide techniques (2004) (4)
Increased serum levels of fibrinogen degradation products due to treatment with recombinant tissue-type plasminogen activator for acute myocardial infarction are related to bleeding complications, but not to coronary patency. European Co-operative Study Groups for rt-PA. (1989) (4)
The chest pain patient dilemma and discussion for chest pain units. (2011) (4)
Early discharge of patients with acute myocardial infarction has no adverse psychological consequences (2001) (4)
What have we learned from the recent large trials in acute coronary syndromes without ST-segment elevation? (2000) (4)
Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes. (2002) (4)
Six-month outcomes of percutaneous coronary balloon angioplasty in acute coronary syndromes: Results from the PURSUIT trial. (2004) (4)
The quality of care in acute coronary syndromes. (2002) (4)
Role of echocardiography in the diagnosis and management of infective endocarditis. (2004) (4)
Comparison of stroke rates in patients with acute coronary syndromes and patients with acute myocardial infarction (1998) (3)
From signal/noise to information content/noise. Reconsidering the statistical analysis of continuous ST-segment data streams with gaps: potential optimization of application-specific information content using left, right, and interval censoring. (1994) (3)
Mortality reduction with accelerated tissue plasminogen activator is explained by early coronary patency (1993) (3)
Assessment for prognosis during and after myocardial infarction. A plea for a stratified approach. (1986) (3)
Continuously improving the practice of cardiology. (2004) (3)
Incidence of recurrent myocardial ischemia after intracoronary fibrinolysis in acute myocardial infarction (1982) (3)
No beneficial effect of 24-48 hours abciximab infusion in aspirin and heparin treated acute coronary syndrome patients with elevated troponin without early revascularisation procedures A GUSTO-IV ACS Substudy (2001) (3)
Treatment with cyclosporin and risks of graft rejection in male kidney and heart transplant recipients with non-O blood. (1988) (3)
New findings from the PURSUIT study (1999) (3)
[Treatment of patients with acute coronary syndromes in the Netherlands in 2000-2001; a comparison with other European countries and with the guidelines]. (2004) (3)
Costs and effects in therapy for acute coronary syndromes : The case of abciximab in high-risk patients undergoing percutaneous transluminal coronary angioplasty in the EPIC study : Use of GP IIb/IIIa inhibitors in coronary syndromes: State of the Art (1998) (3)
Contribution of Nursing to Risk Factor Management as Perceived by Patients with Established Coronary Heart Disease (2002) (3)
Increased rate of evolution of QRS changes in patients with acute myocardial infarction. Results from the Vermut Study. (1993) (3)
Clopidogrel and endothelial injury after percutaneous coronary interventions: beyond the antiplatelet effects. (2010) (3)
Managing ST-elevation myocardial infarction (2002) (3)
The European heart journal launches ethics review board. (2013) (3)
901-7 The Survival Advantage of Early Grade 3 Patency After Thrombolysis for Infarction Increases Over Time (1995) (3)
No prognostic significance of chronic infection with Chlamydia pneumoniae in acute coronary syndromes: insights from the Global Utilization of Strategies to Open Occluded Arteries IV Acute Coronary Syndromes trial. (2007) (3)
20 Angina pectoris (2008) (2)
What is preferable in unstable angina, beta-blockade or calcium-inhibition? (1983) (2)
Abstract 5066: The Treatment Effect of Perindopril is Consistent in All Patients with Vascular Disease or High Risk of Vascular Disease: A Combined Analysis of Three Perindopril Trials (2008) (2)
The influence of ABO blood groups on the incidence of cardiac allograft rejection in males. (1989) (2)
Use of the fluid column in a cardiac catheter for emergency pacing. (1983) (2)
Effect of intracoronary thrombolytic therapy on global and regional left ventricular function. A three year experience with randomization. (1985) (2)
Temporal Evolution of Serum Concentrations of High‐Sensitivity Cardiac Troponin During 1 Year After Acute Coronary Syndrome Admission (2020) (2)
Extra myoglobin peaks corroborate the diagnosis of stuttering infarction (1993) (2)
OKT3 delays rejection crises after heart transplantation. (1989) (2)
Should all patients with an acute myocardial infarction be referred for direct PTCA? (2004) (2)
Continuous ST-Segment Monitoring: Indications and Limitations (1982) (2)
[Earlier treatment of acute myocardial infarction with administration of alteplase (rt-PA) before hospitalization]. (1990) (2)
Pressure gradient and cross sectional area stenosis in patients with and without exertional angina: What is a “critical stenosis?” (1982) (2)
Efficacy of a reduced lead set for pre-hospital triage of thrombolytic strategies (2004) (2)
Nifedipine in the Treatment of Angina (1984) (2)
The Survival Advantage of Early Complete Reperfusion (TIMI Grade 3) After Infarction Doubles Between 30 Days and 2 Years (1995) (2)
Complete coronary perfusion (TIMI flow 3) improves prognosis after myocardial infarction but not incomplete (TIMI 2) perfusion (1993) (2)
Disturbed liver function in heart transplantation candidates: two case reports. (1989) (2)
Emergency Pacing Using the Fluid Column of a Cardiac Catheter (1983) (2)
Improved prognosis during and after myocardial infarction: a plea for an integrated and stratified approach. (1986) (2)
Integrating GP IIb/IIIa inhibitors in the management of acute coronary syndromes (2000) (2)
Beta‐blockers and calcium antagonists in the treatment of prolonged anginal pain at rest: recent evidence from clinical trials (1987) (2)
Can thrombolysis prevent ischemic heart failure? (1988) (2)
Unstable angina pectoris (1987) (2)
How can the European Society of Cardiology ensure compliance with ethical standards? (2016) (2)
The Euro Heart Survey program: what's in it for nurses? (2007) (2)
Left ventricular performance in unstable angina: assessment with radionuclide techniques. (1985) (2)
Angiotensin-converting enzyme inhibition by perindopril in cardiovascular disease (2009) (2)
Alinidine, a new drug for treatment of sinus tachycardia in myocardial infarction or cardiogenic shock (1982) (2)
Intracoronary streptokinase in acute myocardial infarction. A review. (2009) (1)
The european society of cardiology into the next decade. (2000) (1)
Computer analysis of the exercise ECG: new aspects. (1981) (1)
The Clinical Trials of the European Cooperative Study for Recombinant Tissue-Type Plasminogen Activator (rt-PA) (1994) (1)
No change in pharmacokinetic profile of enoxaparin when used as an adjunct to streptokinase thrombolysis in acute myocardial infarction Results of the AMI-SK study (2001) (1)
Use of the Pulmonary Artery Catheter for Cardiac Pacing and Recording of the Intracardiac Electrocardiogram (1985) (1)
Stroke in Patients With Acute Coronary Syndromes Incidence and Outcomes in the Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) Trial Clinical Investigation and Reports (1999) (1)
Imaging of a non-coronary sinus of Valsalva aneurysm with transthoracic echocardiography and multi-slice computed tomography. (2002) (1)
Quantitative assessment of regional left ventricular motion after early thrombolysis using endocardial landmarks (1986) (1)
The Use of Abciximab in Therapy-Resistant Unstable Angina (1999) (1)
[Abciximab: a new antiplatelet agent for use in coronary angioplasty]. (1998) (1)
Effect of ST-567 (a specific bradycardiac agent) in patients with unstable angina and myocardial infarction. (1987) (1)
Electrocardiography During Exercise in Patients with Coronary Sclerosis and Normal Electrocardiogram at Rest. Comparison with Findings from Coronary Arteriography (1971) (1)
Optimizing treatment of acute coronary syndromes with GP IIb/IIIa inhibitors : proceedings of the satellite symposium to the XXIst Congress of the European Society of Cardiology, Barcelona, Spain, August 1999 (2000) (1)
Abstracts selected for presentation at the XXIII Congress of the European Society of Cardiology, together with the 36th Annual General Meeting of the Association for European Paediatric Cardiology (AEPC), September 1–5,2001, Stockholm, Sweden (2001) (1)
[Thrombolytic therapy of acute heart infarct]. (1989) (1)
Costbenefit analysis ofearly thrombolytic treatment withintracoronary streptokinase Twelve monthfollow upreport oftherandomised multicentre trial conducted bytheInteruniversity Cardiology Institute ofTheNetherlands (1988) (1)
Abstract 3781: Long-Term Effect of Perindopril on Coronary Atherosclerosis Progression: Results from the Multicenter, Randomized PERindopril's Prospective Effect on Coronary aTherosclerosis by Angiography and IntraVascular Ultrasound Evaluation (PERSPECTIVE) Study, an EUROPA Substudy (2006) (1)
Risk assessment and longterm survival after thrombolytic therapy (1993) (1)
Early experience with implantable dual chamber defibrillators (1999) (1)
Abciximab associated thrombocytopenia: evidence for a complex interaction with heparin (1998) (1)
Improved electrocardiographic criteria for confirmation of acute myocardial infarction with application in pre-hospital thrombolysis (1995) (1)
Thrombin inhibitors in acute coronary artery disease (2002) (1)
Late results of reperfusion with intracoronary streptokinase. (1985) (1)
E V ect of adopting a new histological grading system of acute rejection after heart transplantation (1998) (1)
Recording the right atrial electrogram through the fluid column of a pulmonary artery catheter. (1985) (1)
Risk stratification of acute coronary syndromes (2004) (1)
Quantitative analysis of exercise electrocardiograms. (1978) (1)
Acute Coronary Syndrome Patients Benefit from Platelet Glycoprotein IIb/IIIa Inhibition as Part of an Initially Medical Treatment Strategy: Results of a Meta-Analysis of Phase III Randomized Trials (2001) (1)
The Value of Holter Monitoring for Detection of Ischemic Heart Disease (1982) (1)
Abstracts selected for presentation at the European Society of Cardiology Congress 31 August–4 September 2002, Berlin - Germany (2002) (1)
Correlation between clinical course and quantitative analysis of the ischemia related artery in patients with unstable angina pectoris, refractory to medical treatment (1994) (1)
Abciximab (ReoPro) in the treatment of acute myocardial infarction and primary PTCA: final results of the GRAPE pilot study (1997) (1)
Acute Consequences of Ischemic Myocardial Damage (1989) (1)
Compensatory Hyperkinesis : The Ejection Fraction 'Equalizer' after MI (1994) (1)
Treatment of unstable angina with emphasis on calcium antagonists. (1984) (1)
Functional Status Following Stroke After Thrombolytic Therapy - Results From the GUSTO Trial (1994) (1)
A half ounce of prevention ... (2011) (1)
Institutional report - Coronary Prognosis of patients undergoing cardiac surgery and treated with intra-aortic balloon pump counterpulsation prior to surgery: a long-term follow-up study (2009) (1)
Review of other trials (1987) (1)
Iconographies supplémentaires de l'article : Costs and effects in therapy for acute coronary syndromes: The case of abciximab in high-risk patients undergoing percutaneous transluminal coronary angioplasty in the EPIC study (2011) (1)
Partnership in cardiovascular medicine. A key to success not only for professional organizations. (2001) (1)
ST Segment Monitoring Substudy patients with myocardial infarction treated with thrombolytic therapy: the GUSTO-I Prognostic significance of ST segment shift early after resolution of ST elevation in (2011) (0)
Clinical benefit, survival and adverse events in patients with implantable cardioverter defibrillators: the initial Rotterdam experience. (2001) (0)
Correlation between clinical course and quantitative analysis of the ischemia related artery in patients with unstable angina pectoris, refractory to medical treatment. Results of two randomized trials. The European Cooperative Study Group. (1994) (0)
[Improved prognosis for patients with early thrombolysis in acute heart infarct]. (1986) (0)
Effects of recanalisation on global left ventricular function in acute myocardial infarction (1985) (0)
Follow-up studies after streptokinase for acute coronary thrombosis: status in 1983. (1985) (0)
Grafting: Results of the EXPEDITION Study Ischemic Cardiac Events in Patients Undergoing Coronary Artery Bypass Sodium-Hydrogen Exchange Inhibition by Cariporide to Reduce the Risk of (2013) (0)
Tilburg University The additional value of patient-reported health status in predicting 1-year mortality after invasive coronary procedures (2007) (0)
Cardiogenic shock among patients with acute coronary syndromes without persistent ST-segment elevation Frequency, outcome, and predictors (1999) (0)
[Thrombolytic therapy of acute heart infarct in 1988]. (1989) (0)
Towards individualized preventive therapy. (2010) (0)
[Differences between hospitals in outcome after a stroke are only partially explained by differences in the quality of care]. (2008) (0)
CONTINUOUS 12-LEAD ST-SEGMENT RECOVERY PREDICTS OUTCOME IN ACUTE MYOCARDIAL INFARCTION BETTER THAN SNAPSHOT ANGIOGRAMS OF TIMI FLOW (1998) (0)
[Thrombolytic therapy in fresh myocardial infarct]. (1987) (0)
Randomized trial with intracoronary streptokinase versus placebo (The Netherlands) (1986) (0)
Management of Acute Coronary Syndrome (2013) (0)
Does the presence of electrocardiographic left ventricular hypertrophy predict one-year mortality in non-ST elevation acute coronary syndromes? (2003) (0)
Subject Index Vol. 101, 2004 (2004) (0)
Differential effect of thrombolytic therapy. (1988) (0)
Reocclusion/restenosis after coronary artery bypass surgery, percutaneous transluminal coronary angioplasty and thrombolysis. (1989) (0)
Iconographies supplémentaires de l'article : Rationale and clinical evidence for the use of GP IIb/IIIa inhibitors in acute coronary syndromes (2011) (0)
One-year follow-up of mortality in the GUSTO IV trial evaluating the effects of 24 – 48 hours abciximab infusion in noninvasively managed acute coronary syndrome patients (2002) (0)
[An unexpected complication of exercise testing]. (1990) (0)
Polyclonal versus monoclonal rejection prophylaxis after heart transplantation: a randomised study (1992) (0)
Standard Treatment ( CAPTURE ) ECG-Ischemia Monitoring in Patients With Unstable Angina Refractory to Reduction of Recurrent Ischemia With Abciximab During Continuous (1998) (0)
Exercise stress testing. (1978) (0)
Abstract 2456: Strong and Independent Association between Angiotensinogen Gene Polymorphisms and Hypertension in 10060 Patients with Stable Coronary Artery Disease (2008) (0)
A selection of abstracts to be presented at the XVIIth Congress of the European Society of Cardiology, August 20–24,1995, Amsterdam, The Netherlands (1995) (0)
Results of heart transplantation at Rotterdam, the Netherlands: 1985 to March 1986. (1986) (0)
242 Cardiovascular Benefits Of Perindopril In Coronary Artery Disease Patients With Hypertension. New Findings From The Europa Study According Jnc-7 Definition Of Hypertension (2010) (0)
Abstract 3714: Heme Oxygenase 1 Determines the Outcome of Vulnerable Plaque (2008) (0)
An individual approach to thrombolytic therapy in patients with evolving myocardial infarction (1995) (0)
coronary revascularisation echocardiography in patients with previous Prognostic value of dobutamine stress (2006) (0)
[Mortality and cause of death in a coronary care unit]. (1986) (0)
Thrombolytic therapy for acute coronary obstruction: status in 1985 (1986) (0)
In-hospital and discharge utilization of medications in patients with and without heart failure presenting with acute coronary syndromes: Insights from the PURSUIT study (2003) (0)
GUIDELINES ON THE MANAGEMENT OF STABLE ANGINA PECTORIS (ENDING) (2007) (0)
Survey quality of care . Data from the Netherlands Stroke stroke is only partly explained by differences in Variation between hospitals in patient outcome after (2008) (0)
Quality Control in Exercise Testing, with Special Reference to Computer Processing of Exercise Electrocardiograms (1984) (0)
Regional Variation in Outcomes as Determined by Investigators and Clinical Events Committee in an International Trial of Eptifibatide in Non-ST Segment Elevation Acute Coronary Syndromes (1998) (0)
[LDL cholesterol lowering therapy: no target value but personalised treatment]. (2015) (0)
[PP.13.01] THE TREATMENT BENEFIT OF THE ACE-INHIBITOR PERINDOPRIL ON TOP OF BETA-BLOCKER THERAPY IN PATIENTS WITH VASCULAR DISEASE (2016) (0)
Thrombolytic therapy for acute coronary obstruction: status in 1986. (1986) (0)
Platelet Glycoprotein IIb/IIIa Receptor Inhibition in Non–ST-Elevation Acute Coronary Syndromes Early Benefit During Medical Treatment Only, With Additional Protection During Percutaneous Coronary Intervention Brief Rapid Communication (1999) (0)
Contents Vol. 98, 2002 (2003) (0)
Subject Index, Vol. 75, 1988 (1988) (0)
Limitations ofaQRSscoring systemtoassessleft ventricular function andprognosis athospital discharge after myocardial infarction (1985) (0)
Does the extent of ST-segment depression predict short- and long-term mortality in patients with non-ST segment elevation acute coronary syndromes? Insights from the GUSTO IV (2003) (0)
Thrombolytic therapy and PTCA in acute myocardial thrombosis (1990) (0)
[Abandon LDL cholesterol target levels]. (2014) (0)
Coronary heart disease Predictors of stroke within 30 days in patients with non-ST-segment elevation acute coronary syndromes (2006) (0)
Improved electrocardiographic criteria in acute myocardial infarction patients increases eligibility for prehospital thrombolysis (1996) (0)
CardioPulse: Ethical issues for the European Society of Cardiology. (2016) (0)
761 Dynamic 3D echocardiography in virtual reality (2005) (0)
ESC news and appointments (2000) (0)
PREHOSPITAL TRIAGE IN ACUTE CHEST PAIN PATIENTS USING A COMPUTER-ASSISTED DECISION RULE (1998) (0)
774 Surgical validation of real-time 3-D echocardiographic assessment of atrioventricular septal defects (2005) (0)
[Use of thrombolytic agents in early myocardial infarction. A review in 1987]. (1988) (0)
Abnormal skeletal muscle mitochondrial oxidative phosphorylation in severe chronic heart failure (2003) (0)
Abstract 4303: Heme Oxygenase 1 Expression in Dendritic Cells Drives Cd4+ T Cell Activation in Transplantation Atherosclerosis (2008) (0)
The Clinical Value of Computer Assistance in the Exercise Laboratory (1982) (0)
Protection against reperfusion injury with ITF-1697 in acute myocardial infarction: The PARI-MI trial (2003) (0)
Thrombolysis With and Without PTCA in Acute Myocardial Infarction (1987) (0)
827-4 N terminal pro brain natriretic peptide is the most powerful predictor of long-term mortality in diabetic patients with acute coronary syndromes (2004) (0)
Automation in cardiology (1981) (0)
817 Cardiology Audit and Registration Data Standards (CARDS) electrophysiology project — standards after pilot phase to test for feasibility (2005) (0)
Enzymetestsintheevaluation ofthrombolysis in acutemyocardial infarction (1988) (0)
755-6 Neurosurgical Evacuation for Intracranial Hemorrhage Associated with Improved Outcome in GUSTO (1995) (0)
908-109 Incremental Prognostic Value of Electrocardiographic Findings when Added to Baseline Clinical Variables in Patients with Acute Myocardial Infarction (1995) (0)
Prognosticsignificance ofnonfatal myocardialreinfarction insurvivors ofa first infarction (2001) (0)
Role ofechocardiograph intedagnosis and management of infective endocarditis (2004) (0)
hort-and Long-Term Risk tratification in Acute Coronary Syndromes (2006) (0)
High saturated fat intake in hyperlipidemic patients is related to male gender, smoking, alcohol intake and obesity (1999) (0)
New Applications for Real-Time Three-Dimensional Echocardiography (2008) (0)
A selection of abstracts to be presented at the XVIIIth Congress of the European Society of Cardiology, August 25–29,1996, Birmingham, United Kingdom (1996) (0)
Evaluation of thrombolytic and monoclonal platelet GPIIb/IIIa receptor antibody therapy in refractory unstable angina pectoris: correlation between quantitative assessment of coronary angiograms and clinical course (1994) (0)
Congenital Aortic Stenosis in Adults (2005) (0)
Long-term coronary Acute myocardial infarction (0)
Subject Index Vol. 98, 2002 (2003) (0)
LEFT VENTRICULAR AND BACKGROUND COUNT DENSITIES AVERAGED OVER ALL STUDIES IN THE THREE DIFFERENT GROUPS LEAP coll (2006) (0)
Estimation of probability of coronary disease by quantitative thallium scintigraphy (1984) (0)
Use of GP IIb/IIIa inhibitors in coronary syndromes : state of the art : proceedings of an international rounstable held in Davos, Switzerland, 15-16 February 1997 (1998) (0)
Inpharzam medical forum--'heart failure today'. (1988) (0)
Combined clinical and pharmacogenetic risk scoring model determines ACE-inhibitor treatment benefit in patients with stable coronary artery disease (2013) (0)
The need for a benchmark of the practice of cardiology (2012) (0)
Long-term mortality of chest pain patients managed according to a decision scheme that aims to avoid inappropriate hospitalisations. (2003) (0)
Abciximab partially attenuates adverse events associated with trombocytopenia: analysis of GUSTO IV ACS (2002) (0)
Continuouslyimprovingthepractice of cardiology (2004) (0)
Recombinant tissue-type plasminogen activator for acute myocardial infarction: must dose be indexed for body weight? (1988) (0)
The use of cardiac catheterization and coronary angioplasty post myocardial infarction in Europe: observations from the GUSTO I trial (1996) (0)
[The operation of an exercise-electrocardiographic service for family physicians; a description of 498 patients]. (1993) (0)
[OP.4A.11] THE TREATMENT BENEFIT OF THE ACE-INHIBITOR PERINDOPRIL ON TOP OF BETA-BLOCKER THERAPY IN PATIENTS WITH VASCULAR DISEASE AND HYPERTENSION (2017) (0)
[Risks and precautions in stress testing]. (1979) (0)
The combination of troponin and CRP levels at admission: a strong prognostic indicator of one-year mortality in both men and women with unstable coronary artery disease (2002) (0)
Computer-assisted exercise testing. (1978) (0)
A combination of pro-BNP och troponin T at baseline provide the best prediction of risk of death and myocardial infarction early after acute coronary syndrome (2003) (0)
infarction be referred for direct PTCA? Should all patients with an acute myocardial (2006) (0)
1313: Management of ST-Elevation Acute Coronary Syndrome Patients. A Nurses' View on the Euro Heart Survey on Acute Coronary Syndromes (2004) (0)
A comparison ofmethods ofanalysing exercise tests fordiagnosis ofcoronary arterydisease (1989) (0)
Contents Vol. 101, 2004 (2004) (0)
[Prognosis of the uncomplicated first heart infarct in patients less than 60 years of age: a reason for heart catheterization?]. (1986) (0)
A Comparison of Static Serial vs Continuous ST-Segment Recovery to Predict Outcome After Lytics for MI (1998) (0)
Thrombolytic Agents in Early Myocardial Infarction — An Overview in 1987 (1988) (0)
The Use of Abciximab in Therapy-Resistant Unstable Angina: Clinical and Angiographic Results of the CAPTURE Pilot Trial and the CAPTURE Study (2003) (0)
[Initial Dutch experiences with heart transplantation]. (1986) (0)
Is Optimal Streptokinase Treatment Possible for Every Patient with Myocardial Infarction (1984) (0)
Costs and effects in therapy for acute coronary syndromes: the case of abciximab in high-risk patients undergoing percutaneous transluminal coronary angioplasty in the EPIC study. Evaluation of 7E3 for the Prevention of Ischemic Complications. (1998) (0)
Prognostic significance of ST segment monitoring early after myocardial infarction: GUSTO ECG substudy (1996) (0)
UPDATE programmes of the European Society of Cardiology. (2012) (0)
Meeting Report ESC Forum on Drug Eluting Stents European Heart House, Nice, 27 – 28 2007 (2009) (0)
Evaluation of the application and applicability of (European) treatment guidelines on heart failure, valvular heart disease, coronary revascularisation and stable angina (2003) (0)
Evaluation of reduced lead sets for reconstruction of the 12-lead ECG (2004) (0)
Meeting Report ESC Forum on Drug Eluting Stents European Heart House, Nice, 27 – 28 2007 (2009) (0)
abciximab therapy Occurrence and clinical significance of pseudothrombocytopenia during (2011) (0)
Does early abciximab improve angiographic outcome and left ventricular function in patients with acute MI? (2007) (0)
Riskstratificationforsuddencardiacdeath:current status and challenges for the future † (2014) (0)
[Thrombolysis in patients with acute heart infarct]. (1986) (0)
Introduction to imaging of the heart: Contrast angiography, digital angiography, nuclear imaging, echocardiography (1984) (0)
[Early thrombolysis improves the long-term prognosis for patients with a heart infarct]. (1990) (0)
Hot topics: arrhythmias (2011) (0)
Costs and benefits of treatment of myocardial infarction (2013) (0)
[Prognositc value of hemodynamic surveillance in acute myocardial infarct]. (1976) (0)
Assessment of international differences in 30-day event of death and reinfarction amongst patients with acute coronary syndromes: insights from GUSTO IV ACS (2002) (0)
Lower respiratory tract infections after out-of-hospital cardiac arrest treated with induced hypothermia (2008) (0)
Pioneers in cardiology: Maarten Simoons, MD. Interview by Robert Short. (2006) (0)
Abstract 760: Heme Oxygenase-1 expression in Dendritic Cells determines the Outcome of Transplantation Arteriosclerosis (2007) (0)
Clinical predictors of ACE-inhibitor induced dry cough in 27492 patients with cardiovascular disease using individual data of randomized clinical trials (2013) (0)
Interpretation of trials with drugs and devices; a double standard? (1996) (0)
Abstract 2761: Increase of 1-Year Mortality After Perioperative Beta-Blocker Withdrawal in Vascular Surgery Patients (2006) (0)
Predictors of one-year death in men and women: GUSTO-IV acute coronary syndrome (2003) (0)
1042-78 Does chronic infection with chlamydia pneumoniae influence the prognosis of acute coronary syndromes? insights from a nested matched case-control substudy of the GUSTO IV acute coronary syndromes trial (2004) (0)
[Delay in hospitalization of patients with myocardial infarct]. (1993) (0)
[Ventricular arrhythmia during physical exercise. A comparative study in healthy men and in patients with coronary disease]. (1977) (0)
Criteria for ischemia quantification in unstable angina trials: The CAPTURE experience (1998) (0)
[Promotion of rapid and oriented referral of patients with possible heart infarct by ECG at home]. (1995) (0)
Ventricular septal rupture as an early and fatal complication of acute myocardial infarction: case report (2006) (0)
Changes inleft ventricular function andwall thickness inheart transplant recipients andtheir relation toacuterejection: an assessmentby digitised M modeechocardiography (1992) (0)
[Exercise electrocardiography. The importance of the patient selection for the interpretation of the exercise test]. (1977) (0)
P Biomarkers and Coronary Disease roponin-T and N-Terminal ProB-Type atriuretic Peptide Predict Mortality Benefit From oronary Revascularization in Acute Coronary Syndromes (2006) (0)
Nifedipine and metoprolol in suspected unstable angina. Unstable angina pectoris. (1987) (0)
gender on prognosis Seven-year follow-up after dobutamine stress echocardiography: Impact of (2011) (0)
age subgroups coronary syndromes: Benefit and harm in different blockers in non-ST-segment elevation acute Effects of platelet glycoprotein IIb/IIIa receptor (2008) (0)
Abstract 15226: High Prevalence of Early Repolarization in Patients With Noncompaction Cardiomyopathy Presenting With Malignant Ventricular Arrhythmias. (2010) (0)
The grey zone of truth. (2014) (0)
227 Detection of coronary artery disease during recovery phase of stress echocardiography (2006) (0)
Abstract 4436: Direct Relation between Angiotensin-Converting Enzyme (ACE) Gene Polymorphisms and Hypertension in Patients with Stable Coronary Artery Disease (2008) (0)
protein concentrations in plasma myocardial infarction using fatty acid binding Assessment of coronary reperfusion in patients with (2001) (0)
[National guidelines for clinical decisions, a methodological view]. (1998) (0)
A fatality during exercise testing. (1990) (0)
[Practice guidelines for physicians and related economic considerations]. (1999) (0)
[Some thoughts on the education of junior and senior interns and residents]. (1970) (0)
Thrombolytic Therapy forAcute Coronary Obstruction: Status in1986 (1986) (0)
[Estimation of risk of death in the first year following a heart infarct; the value of clinical studies, stress testing, radionuclide angiography and 24-hour electrocardiography]. (1986) (0)
Patient Selection for Thrombolytic Therapy for Evolving Myocardial Infarction (1997) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With M. L. Maarten L. Simoons?

M. L. Maarten L. Simoons is affiliated with the following schools: